Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

National Vaccine Information Center Says U.S. Supreme Court Betrayed Consumers

By Pharmaceutical Processing | February 23, 2011

The National Vaccine Information Center (NVIC), whose co-founders
worked with Congress on the National Childhood Vaccine Injury Act of 1986
(PL-99-660), is calling yesterday’s U.S. Supreme Court decision giving drug
companies total liability protection for injuries and deaths caused by government
mandated vaccines a “betrayal” of the American consumer.

In a 6-2 decision, the Court majority voted to reject
substantial evidence in the Act’s legislative history that the 99th Congress
fully intended to protect an American’s right to sue a pharmaceutical corporation
for injuries that could have been prevented if the company had elected to make
a safer vaccine.

 NVIC co-founder and
president Barbara Loe Fisher, said “Parents of vaccine injured children,
who worked in good faith with Congress in the early 1980’s on the 1986 law,
have been betrayed by six American judges, who ignored congressional intent and
threw victims of vaccine injury under the bus in order to give complete
liability protection to a wealthy industry with a long history of hiding their
products’ risks. They have removed the safety net we were promised. If we had known
this day would come, we would have vigorously opposed any federal legislation
that limited civil liability for drug corporations now making substantial
profits from vaccines mandated by government.” Hannah Bruesewitz was brain
injured by DPT vaccine as a child but she was denied compensation by the U.S.
Court of Claims, which administers the federal vaccine injury compensation
program created by the 1986 Act that has turnedaway two out of three
plaintiffs. Her attorneys then sued in civil court, providing evidence that
Wyeth-Lederle had the technology to produce a less reactive, purified pertussis
vaccine but declined to do so.

“The U.S. Supreme Court has removed all financial
incentive for multi-national pharmaceutical corporations, which enjoy a $20
billion dollar business, to make vaccines as safe as they can be,” said Fisher.
“This is a sad day for all Americans forced by law to use dozens of doses
of vaccines or be barred from school or health insurance or employment. The
only leverage left to American consumers to ensure that vaccines with the
fewest health risks are produced is to oppose vaccine mandates and work to
defend vaccine exemptions in all public health laws.” The National Vaccine Information
Center is a non-profit
charity founded in 1982 to prevent vaccine injuries and deaths through public education.
NVIC co-founders were responsible for inclusion of vaccine safety and research
provisions in the 1986 Act, including the Vaccine Adverse Events Reporting
System, and for ensuring that the Act protected the right of those injured by
vaccines to access the civil court system if they were turned down for
compensation or offered too little to meet their lifetime medical care needs.

NVIC has been critical of the failure of the U.S.
Departments of Justice and Health and Human Services to implement the 1986 law
in accordance with legislative language, history and congressional intent.   

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE